Altimmune, Inc.
ALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326190
In the last 90 days, Altimmune, Inc. insiders filed 1 open-market purchase and 0 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $456.1M in total; Viking Global Investors is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Altimmune, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 98 | 109 | +11 |
| Shares | 23.8M | 27.3M | +3.43M (+14.4%) |
| Value | $336.5M | $269.2M | −$67.4M (−20.0%) |
New holders (42)
Institutions that held Altimmune, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (31)
Institutions that held Altimmune, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.